Literature DB >> 26723877

Complement proteins C7 and CFH control the stemness of liver cancer cells via LSF-1.

Hyang Sook Seol1, Sang Eun Lee1, Joon Seon Song2, Je-Keun Rhee3, Shree Ram Singh4, Suhwan Chang5, Se Jin Jang6.   

Abstract

Tumor-initiating cells are important for the formation and maintenance of tumor bulks in various tumors. To identify surface markers of liver tumor-initiating cells, we performed primary tumorsphere culture and analyzed the expression of cluster of differentiation (CD) antigen genes using NanoString. Interestingly, we found significant upregulation of the complement proteins (p = 1.60 × 10(-18)), including C7 and CFH. Further studies revealed that C7 and CFH are required to maintain stemness in liver cancer cells. Knockdown of C7 and CFH expression abrogated tumorsphere formation and induced differentiation, whereas overexpression stimulated stemness factor expression as well as in vivo cell growth. Mechanistically, by studying C7 and CFH-dependent LSF-1 expression and its direct role on stemness factor transcription, we found that LSF-1 is involved in this regulation. Taken together, our data demonstrate the unprecedented role of complement proteins on the maintenance of stemness in liver tumor-initiating cells. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  CFH; Complement protein C7; HCC; LSF-1; Liver tumor-initiating cell; Stemness factor

Mesh:

Substances:

Year:  2015        PMID: 26723877      PMCID: PMC4744505          DOI: 10.1016/j.canlet.2015.12.005

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  28 in total

Review 1.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 2.  Cancer stem cells: mirage or reality?

Authors:  Piyush B Gupta; Christine L Chaffer; Robert A Weinberg
Journal:  Nat Med       Date:  2009-09-04       Impact factor: 53.440

3.  The transcription factor LSF: a novel oncogene for hepatocellular carcinoma.

Authors:  Prasanna K Santhekadur; Devaraja Rajasekaran; Ayesha Siddiq; Rachel Gredler; Dong Chen; Scott E Schaus; Ulla Hansen; Paul B Fisher; Devanand Sarkar
Journal:  Am J Cancer Res       Date:  2012-04-21       Impact factor: 6.166

Review 4.  The role of inflammation and liver cancer.

Authors:  Anupam Bishayee
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

Review 5.  Tumour immunity: effector response to tumour and role of the microenvironment.

Authors:  Alberto Mantovani; Pedro Romero; A Karolina Palucka; Francesco M Marincola
Journal:  Lancet       Date:  2008-02-13       Impact factor: 79.321

Review 6.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

7.  Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma.

Authors:  Pilvi M Riihilä; Liisa M Nissinen; Risto Ala-Aho; Markku Kallajoki; Reidar Grénman; Seppo Meri; Sirkku Peltonen; Juha Peltonen; Veli-Matti Kähäri
Journal:  J Invest Dermatol       Date:  2013-08-12       Impact factor: 8.551

8.  Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells.

Authors:  Michael G Strainic; Jinbo Liu; Danping Huang; Fengqi An; Peter N Lalli; Nasima Muqim; Virginia S Shapiro; George R Dubyak; Peter S Heeger; M Edward Medof
Journal:  Immunity       Date:  2008-03-06       Impact factor: 31.745

9.  Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction.

Authors:  Qi Peng; Ke Li; Katie Anderson; Conrad A Farrar; Bao Lu; Richard A G Smith; Steven H Sacks; Wuding Zhou
Journal:  Blood       Date:  2007-12-04       Impact factor: 22.113

10.  Autocrine effects of tumor-derived complement.

Authors:  Min Soon Cho; Hernan G Vasquez; Rajesha Rupaimoole; Sunila Pradeep; Sherry Wu; Behrouz Zand; Hee-Dong Han; Cristian Rodriguez-Aguayo; Justin Bottsford-Miller; Jie Huang; Takahito Miyake; Hyun-Jin Choi; Heather J Dalton; Cristina Ivan; Keith Baggerly; Gabriel Lopez-Berestein; Anil K Sood; Vahid Afshar-Kharghan
Journal:  Cell Rep       Date:  2014-03-06       Impact factor: 9.423

View more
  20 in total

1.  Evaluation of Serum and Gene Expression of Galectin-4, Interleukin-27, and Complement-7 in Hepatitis C Virus-Infected Egyptian Patients.

Authors:  Marwa S Abdel-Tawab; Hanan H Fouad; Dalia A Omran; Aml E Abdou; Shaimaa Mohamed Zaied; Alaa A Mohamed
Journal:  Biomed Res Int       Date:  2020-12-15       Impact factor: 3.411

2.  Characteristic proteins in the plasma of postoperative colorectal and liver cancer patients with Yin deficiency of liver-kidney syndrome.

Authors:  Qing Ji; Wenhai Wang; Yunquan Luo; Feifei Cai; Yiyu Lu; Wanli Deng; Qi Li; Shibing Su
Journal:  Oncotarget       Date:  2017-10-11

3.  Prognostic Value of Complement Component 2 and Its Correlation with Immune Infiltrates in Hepatocellular Carcinoma.

Authors:  Gang Ning; Yan-Lin Huang; Li-Min Zhen; Wen-Xiong Xu; Xue-Jun Li; Li-Na Wu; Ying Liu; Chan Xie; Liang Peng
Journal:  Biomed Res Int       Date:  2020-06-14       Impact factor: 3.411

4.  Complement C3a promotes proliferation, migration and stemness in cutaneous squamous cell carcinoma.

Authors:  Zhuo Fan; Jingjing Qin; Dandan Wang; Songmei Geng
Journal:  J Cell Mol Med       Date:  2019-03-01       Impact factor: 5.310

5.  HOXC6 promotes migration, invasion and proliferation of esophageal squamous cell carcinoma cells via modulating expression of genes involved in malignant phenotypes.

Authors:  Li Tang; Yong Cao; Xueqin Song; Xiaoyan Wang; Yan Li; Minglan Yu; Mingying Li; Xu Liu; Fang Huang; Feng Chen; Haisu Wan
Journal:  PeerJ       Date:  2019-03-14       Impact factor: 2.984

6.  Locus 5p13.1 may be associated with the selection of cancer-related HBV core promoter mutations.

Authors:  Qin-Yan Chen; Yan-Ling Hu; Xue-Yan Wang; Tim J Harrison; Chao Wang; Li-Ping Hu; Qing-Li Yang; Chuang-Chuang Ren; Hui-Hua Jia; And Zhong-Liao Fang
Journal:  Int J Med Sci       Date:  2019-06-10       Impact factor: 3.738

Review 7.  Surgical stress and cancer progression: the twisted tango.

Authors:  Zhiwei Chen; Peidong Zhang; Ya Xu; Jiahui Yan; Zixuan Liu; Wayne Bond Lau; Bonnie Lau; Ying Li; Xia Zhao; Yuquan Wei; Shengtao Zhou
Journal:  Mol Cancer       Date:  2019-09-02       Impact factor: 27.401

8.  ADAMTS12 acts as a tumor microenvironment related cancer promoter in gastric cancer.

Authors:  Yangming Hou; Yingjuan Xu; Dequan Wu
Journal:  Sci Rep       Date:  2021-05-26       Impact factor: 4.379

9.  Differential genomics and transcriptomics between tyrosine kinase inhibitor-sensitive and -resistant BCR-ABL-dependent chronic myeloid leukemia.

Authors:  Neetu Singh; Anil Kumar Tripathi; Dinesh Kumar Sahu; Archana Mishra; Margaret Linan; Bianca Argente; Julia Varkey; Niranjan Parida; Rebecca Chowdhry; Hari Shyam; Nawazish Alam; Shivani Dixit; Pratap Shankar; Abhishek Mishra; Avinash Agarwal; Chris Yoo; Madan Lal Brahma Bhatt; Ravi Kant
Journal:  Oncotarget       Date:  2018-07-13

Review 10.  Role of the complement system in the tumor microenvironment.

Authors:  Ronghua Zhang; Qiaofei Liu; Tong Li; Quan Liao; Yupei Zhao
Journal:  Cancer Cell Int       Date:  2019-11-15       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.